Breast cancer Drug's heart risk: finding the best checkup schedule
NCT ID NCT02696707
Summary
This study aimed to find the best schedule for checking heart health in patients receiving trastuzumab, a life-saving breast cancer drug that can sometimes weaken the heart. Researchers compared two different standard monitoring plans in 200 patients with early-stage breast cancer. The goal was to gather information to help doctors protect patients' hearts without interrupting their cancer treatment unnecessarily.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Southlake Regional Health Centre
Newmarket, Ontario, L3Y 2P9, Canada
-
The Ottawa Hospital
Ottawa, Ontario, K1H 8L6, Canada
-
The Ottawa Hospital Cancer Centre
Ottawa, Ontario, K2H 8L6, Canada
-
Thunder Bay Regional Health Sciences Centre
Thunder Bay, Ontario, P7B 6V4, Canada
Conditions
Explore the condition pages connected to this study.